 PALO ALTO, Calif. and SUZHOU, China, March 02, 2022 GLOBE NEWSWIRE -- Gracell Biotechnologies Inc. NASDAQ: GRCL Gracell, a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that it plans to release unaudited financial results for the fourth quarter and full year 2021, and provide an update on recent business developments on Monday, March 14, 2022. The management team will host a live audio webcast and conference call at 8:00AM Eastern Time. 